Kvetiapin Pharmas

Quetiapine, the active ingredient in Kvetiapin Pharmas, is an atypical antipsychotic presented as an oral tablet for oral use. It is used to treat schizophrenia, bipolar disorder and as an adjunct in major depressive disorder in adults.

GNH USA supplies Kvetiapin Pharmas as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Quetiapine is an atypical antipsychotic used in several psychiatric conditions.

- Schizophrenia: reduces hallucinations, delusions and other psychotic symptoms. - Bipolar disorder (manic episodes): stabilises mood and diminishes manic excitement. - Bipolar disorder (depressive episodes): alleviates depressive signs and improves functioning. - Major depressive disorder (adjunct): enhances the effect of standard antidepressants when added to therapy.

Quetiapine may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Drowsiness: feeling of sleepiness or fatigue. - Dry mouth: reduced salivation leading to oral discomfort. - Constipation: difficulty passing stool. - Weight gain: increase in body weight over time.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: rare but potentially life‑threatening reaction with fever and muscle rigidity. - Tardive dyskinesia: involuntary movements that may be irreversible. - Orthostatic hypotension: sudden drop in blood pressure causing dizziness or fainting.

When prescribing quetiapine, clinicians should consider several safety measures.

- Cardiovascular monitoring: assess blood pressure and heart rate, especially at treatment initiation. - Metabolic assessment: monitor weight, glucose and lipid levels regularly. - CNS depression: avoid operating machinery or driving if drowsiness occurs. - Pregnancy and lactation: use only if benefits outweigh potential risks; safety data limited. - Drug discontinuation: taper dose gradually under medical supervision to reduce withdrawal symptoms. - Store at ambient temperature: keep below 25°C in original container, protect from moisture and light.

Quetiapine interacts with several drug classes that may require dose adjustment or avoidance.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): can markedly increase quetiapine plasma levels. - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce efficacy by lowering drug concentrations. - CNS depressants (e.g., alcohol, benzodiazepines): additive sedation and respiratory depression risk.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may enhance orthostatic hypotension. - Anticholinergic drugs: may increase anticholinergic burden, worsening dry mouth and constipation.